Effect of Somatostatin Analogues in the Control of Tumor Growth in Patients with Metastatic Lung Carcinoid Tumors

被引：0
|
作者：
Fekih, M. [1 ]
Baudin, E. [1 ]
Ducreux, M. [1 ]
Chougnet, C. [1 ]
Leboulleux, S. [1 ]
Duvillard, P. [1 ]
Deandreis, D. [1 ]
Dromain, C. [1 ]
Schlumberger, M. [1 ]
Guigay, J. [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
来源：
NEUROENDOCRINOLOGY | 2011年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [21] DOES LANREOTIDE INFLUENCE THE GROWTH OF METASTATIC CARCINOID-TUMORS
    RUSZNIEWSKI, P
    ROUGIER, P
    RAMPAL, P
    GRANGE, JD
    JIAN, R
    TREFFOT, MJ
    LESUR, G
    GENESTIN, E
    THOMAS, F
    CHAYVIALLE, JA
    BERNADES, P
    GASTROENTEROLOGY, 1994, 106 (04) : A319 - A319
  • [22] Evaluation of the Combination Oxaliplatin and 5-Fluorouracil or Gemcitabine in Patients with Metastatic Lung Carcinoid Tumors
    Walter, T.
    Planchard, D.
    Bouledrak, K.
    Guigay, J.
    Dussol, A. S.
    Scoazec, J. Y.
    Hervieu, V
    Ducreux, M.
    Lombard-Bohas, C.
    Baudin, E.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 122 - 122
  • [23] Carcinoid tumor of the lung metastatic to a previously identified pituitary adenoma
    Campbell, D.
    Amponsah, N. K.
    Mott, R.
    Ellis, T.
    JOURNAL OF SURGICAL CASE REPORTS, 2012, (10):
  • [24] The Influence of Proliferation Index on Somatostatin Receptor Scan in Patients with Carcinoid Tumors
    Vlajkovic, M.
    Rajic, M.
    Stevic, M.
    Matovic, M.
    Macut, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S588 - S588
  • [25] SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN PATIENTS WITH CARCINOID-TUMORS - COMPARISON BETWEEN RADIOLIGAND UPTAKE AND TUMOR-MARKERS
    KALKNER, KM
    JANSON, ET
    NILSSON, S
    CARLSSON, S
    OBERG, K
    WESTLIN, JE
    CANCER RESEARCH, 1995, 55 (23) : S5801 - S5804
  • [26] Effect of Treatment with Prolonged-Release Somatostatin Analogues on the Concentration of Serum Fibrosis Markers in Patients with Carcinoid Syndrome
    Foltyn, W.
    Zemczak, A.
    Rosiek, V
    Kilian-Kita, A.
    Kos-Kudla, B.
    NEUROENDOCRINOLOGY, 2017, 105 : 197 - 197
  • [27] Effect of dacarbacine (DTIC) on tumor growth in patients with metastatic neuroendocrine gastroenteropancreatic (GEP) tumors.
    Sprenger, A
    Wied, M
    Mueller, HH
    Klose, K
    Arnold, R
    GASTROENTEROLOGY, 2000, 118 (04) : A647 - A647
  • [28] Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs
    Lenotti, Elisa
    Alberti, Andrea
    Spada, Francesca
    Amoroso, Vito
    Maisonneuve, Patrick
    Grisanti, Salvatore
    Baggi, Alice
    Bianchi, Susanna
    Fazio, Nicola
    Berruti, Alfredo
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [29] Efficacy of 177-Lutetium DOTATATE Peptide Receptor Radionuclide Therapy in patients with metastatic NENs and carcinoid syndrome refractory to somatostatin analogues
    Ratnayake, G. M.
    Koffas, A.
    Theocharopoulos, I
    Hayes, A.
    Navalkissoor, S.
    Gnanasegaran, G.
    Quigley, A. M.
    Khoo, B.
    Mandair, D.
    Grossman, A.
    Caplin, M.
    Alsadik, S.
    Clark, R.
    Toumpanakis, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 157 - 157
  • [30] The detrimental impact of unresected primary tumors in patients with metastatic midgut carcinoid tumors
    Campbell, Katherine E.
    Huang, Bin
    Guo, Jing
    Anthony, Lowell B.
    Evers, B. Mark
    McKenzie, Shaun P.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) : S135 - S135
12345